Abivax Announces Pricing of Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary SharesPARIS, France, July 1, 2026 – 2:30 p.m. (CEST) – Abivax SA (Euronext Paris:FR0012333284 – ABVX / NASDAQ:ABVX (“Abivax” or the “Company”), a clinical-stage biotechnology company focused…
Press releaseAtos Named ‘Best in Class’ in Multiple Categories Across the 2026 PAC RADAR Evaluation of SAP Service ProvidersAtos Continued leadership in key segments of SAP landscape, based on decades of experience, is once again recognized by one of most authoritative analyst houses.Bezons, France…
PARIS (dpa-AFX) - French drugmaker Ipsen S.A. (IPSEF.PK, IPSEY, IPN.PA) announced on Wednesday that it has agreed to buy Swiss biotech Memo Therapeutics AG for more than 700 million euros including milestones, targeting potravitug, a Phase II antibody for a serious post-transplant kidney infection…
TotalEnergies listed a Djeno crude cargo for July 27–28 at Dated Brent minus $14/bbl, then withdrew the offer the next Tuesday, removing the July-loading Djeno cargo from the marke
Airbus SE (AIR): SAS ordered up to 40 Airbus widebody jets, a deal worth over $10 billion at list prices. Order names Airbus as the widebody manufacturer; delivery details not give
The acquisition of Cognite for $3.1 billion aims to create a leading industrial AI platform by integrating Cognite’s cloud-native, AI-driven technology with AVEVA and Schneider’s global reach. The deal is expected to accelerate innovation, enhance data intelligence, and drive profitable growth.Base…
The acquisition of Cognite for $3.1 billion aims to create a unified industrial AI platform, leveraging Cognite’s advanced data and AI capabilities with AVEVA’s global reach. The deal is expected to accelerate innovation, enhance energy management, and drive profitable growth.Based on Schneider Ele…
PRESS RELEASEAB SCIENCE ANNOUNCES THE SUCCESSFUL COMPLETION OF A EUR 2.3 MILLION PRIVATE PLACEMENTParis, July 1st, 2026, 8amAB Science S.A. (the “Company” or “AB Science”, Euronext – FR0010557264 – AB) announces today the successful completion of a capital increase of a total gross amount of EUR 2…
DEKUPLE Group continues its European growth with a majority stake acquisition in subko&co in PolandParis, July 1st, 2026 (8:00 a.m.) – DEKUPLE Group, a European leader in communication and data marketing, announces the acquisition of a majority stake in subko&co, a Polish agency combining performan…
EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF CAREDX’s TRANSPLANT LAB PRODUCT DIVISIONParis, July 1st, 2026 ,8 AM CETEurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in in-vitro diagnostics for transplantation, oncology and infectious diseases, today announces th…
Medclair has received an order from another customer in the recycling sector in France, in the Île-de-France region. The order value amounts to over SEK 3 million and covers an integrated solution for the measurement, monitoring, and destruction of nitrous oxide, including a service agreement. The…
The acquisition of Cognite for $3.1 billion in cash aims to combine advanced industrial AI with AVEVA's global reach, creating a unified platform for industrial intelligence and operational efficiency. The deal is expected to close in the coming quarters.Original document: Schneider Electric SE [SU…
ABIVAX/ Key word(s): MiscellaneousAbivax announces temporary trading halt of its ordinary shares on Euronext Paris01.07.2026 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax announces temporary trading halt of its ordinary shares on Euronext ParisPARIS, F…
Abivax announces temporary trading halt of its ordinary shares on Euronext ParisPARIS, France, July 1, 2026 – 07:30 a.m. CEST – Abivax SA (Euronext Paris:FR0012333284 – ABVX) (“Abivax” or the “Company”), a clinical-stage biotechnology company focused on developing therapeutics that harness the body…
Availability of the aide-mémoire for Q2 2026 resultsParis, France – July 1, 2026. Sanofi announced today the availability of the aide-mémoire for Q2 2026 results on the "Investors" page of sanofi.com:Second quarter 2026 resultsPrepared each quarter, this document is intended to support financial mo…
Brockhaus Technologies AG/ Key word(s): Disposal/MiscellaneousBrockhaus Technologies AG: Closing of the sale of the stake in the Bikeleasing Group01.07.2026 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.PRESS RELEASE Brockhaus Technologies AG: Closing of the…
MindMaze Therapeutics Holding SA/ Key word(s): StudyMindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursement Strategy in Europe01.07.2026 / 07:00 CET/CESTMindMaze Therapeutics Enrolls First Patients in SwissNeuroRehab Study, Advancing At-Home Reimbursem…
PARIS, FRANCE AND SCHLIEREN/ZURICH, SWITZERLAND, 01 JULY 2026 - Ipsen Euronext:IPN; ADR:IPSEY and Memo Therapeutics AG announced today they have entered into a definitive share purchase agreement under which Ipsen has agreed to acquire all issued and outstanding shares of Memo Therapeutics AG. The…
Shares of Abivax (ABVX) clocked their best day in about 11 months on Tuesday on the heels of multiple price target revisions and updated safety and efficacy data from a study that addressed prior investor worries about cancer risk tied to its ulcerative colitis candidate, obefazimod.ABVX stock clos…
ABIVAX/ Key word(s): Capital IncreaseAbivax Announces Launch of Public Offering of American Depositary Shares30.06.2026 / 22:48 CET/CESTThe issuer is solely responsible for the content of this announcement.Abivax Announces Launch of Public Offering of American Depositary SharesPARIS, France – June…